Barclays’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10K | Sell |
|
|||||
|
2025
Q1 | $99K | Sell |
|
|||||
|
2024
Q4 | $165K | Buy |
|
|||||
|
2024
Q3 | $332K | Buy |
|
|||||
|
2024
Q2 | $84K | Sell |
|
|||||
|
2024
Q1 | $326K | Sell |
|
|||||
|
2023
Q4 | $510K | Buy |
|
|||||
|
2023
Q3 | $362K | Buy |
|
|||||
|
2023
Q2 | $630K | Sell |
|
|||||
|
2023
Q1 | $579K | Sell |
|
|||||
|
2022
Q4 | $1.16M | Buy |
|
|||||
|
2022
Q3 | $988K | Buy |
|
|||||
|
2022
Q2 | $57K | Sell |
|
|||||
|
2022
Q1 | $164K | Buy |
|